Dna Legal Limited
Registered name: DNA LEGAL LIMITED
Part of Dna Worldwide Group Holdings Limited groupDna Legal Limited made £12.5m revenue and £3.2m profit in the year to 31 Dec 2025.
Dna Legal Limited’s revenue grew 32% to £12.5m in the year to 31 Dec 2025, with £3.2m profit and 55 employees. The company is classified under “research and experimental development on biotechnology” and is based in Frome; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Frome, South West
- Age
- 20 yrs · since 2006
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|
| Disclosure | No P&L | No P&L | Full P&L | Full P&L |
| Profit & loss | ||||
| Revenue (turnover) | — | — | £9.5m | £12.5m |
| Cost of sales | — | — | −£4.1m | −£5.2m |
| Gross profit | — | — | £5.5m | £7.3m |
| Operating profit | — | — | £2.7m | £3.7m |
| Profit before tax | — | — | £2.7m | £3.7m |
| Profit after tax | — | — | £2.5m | £3.2m |
| Profit (best available) | — | — | £2.5m | £3.2m |
| Employees (average) | 31 | 40 | 47 | 55 |
| Ratios | ||||
| Profit margin | — | — | 26% | 25.5% |
| Gross margin | — | — | 57.3% | 58.2% |
| Revenue per employee | — | — | £202k | £228k |
| Profit per employee | — | — | £52.6k | £58.2k |
| Growth (year on year) | ||||
| Revenue growth | — | — | — | ▲32% |
| Profit growth | — | — | — | ▲29.3% |
| Headcount growth | — | ▲29% | ▲17.5% | ▲17% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £890k | £714k | £583k | — |
| Net assets | £2.3m | £1.2m | £1.3m | — |
| Fixed assets | £53k | £44.9k | £45.8k | — |
| Current assets | £3.1m | £2.4m | £2.6m | — |
| Debtors | £886k | £894k | £1.4m | — |
| Source | FullAccounts · bulk data Sep 2024 | FullAccounts · bulk data Sep 2024 | FullAccounts · bulk data Sep 2025 | Accounts · bulk data Sep 2026 |
How the business works
- Profit margin
- 25.5%
- Profit ÷ revenue.
- Gross margin
- 58.2%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £228k
- Revenue ÷ average employees.
- Profit per employee
- £58.2k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- ▲17%
- Now 55
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Dna Worldwide Group Holdings Limitedultimate parent75–100%
- Dna Legal Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Sister companies (5)
- Dna Workplace LimitedFigures not disclosed
- Dna Worldwide Group LtdFigures not disclosed
- Kiamgenics Laboratories LtdFigures not disclosed
- Living Dna LimitedFigures not disclosed
- Mim Integration LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Askbio UK LtdMidlothian · Research and experimental development on biotechnology
- Revenue
- £12.5m
- Profit
- £1.8m
- Staff
- 54
- Theradex (Europe) LimitedRedhill · Research and experimental development on biotechnology
- Revenue
- £15.2m
- Profit
- £3.1m
- Staff
- 43
- Biopharma Process Systems LimitedWinchester · Research and experimental development on biotechnology
- Revenue
- £10.1m
- Profit
- £142k
- Staff
- 66
- Flatiron Health UK LtdST Albans · Research and experimental development on biotechnology
- Revenue
- £9.5m
- Profit
- £239k
- Staff
- 32
- Enara Bio LimitedOxford · Research and experimental development on biotechnology
- Revenue
- £17.4m
- Profit
- £1.3m
- Staff
- 54
- Ligand UK Development LimitedLondon · Research and experimental development on biotechnology
- Revenue
- £8.7m
- Profit
- £6m
- Staff
- —
Sources
Latest figures from accounts for the year to 31 Dec 2025 (profit £3.2m), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.
Updated from Companies House on 12 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.